Estamos realizando la búsqueda. Por favor, espere...
1552
37
171
26541
4223
2557
339
Abstract: Progranulin (PGRN) is a recently identified adipokine that is supposed to have anti-inflammatory actions. The proinflammatory cytokine interleukin-1? (IL1?) stimulates several mediators of cartilage degradation. Toll like receptor-4 (TLR4) can bind to various damage-associated molecular patterns, leading to inflammatory condition. So far, no data exist of PGRN effects in inflammatory conditions induced by IL1? or lipopolysaccharide (LPS). Here, we investigated the anti-inflammatory potential of PGRN in IL1?- or LPS-induced inflammatory responses of chondrocytes. Human osteoarthritic chondrocytes and ATDC-5 cells were treated with PGRN in presence or not of IL1? or LPS. First, we showed that recombinant PGRN had no effects on cell viability. We present evidence that PGRN expression was increased during the differentiation of ATDC-5 cell line. Moreover, PGRN mRNA and protein expression is increased in cartilage, synovial and infrapatellar fat pad tissue samples from OA patients. PGRN mRNA levels are upregulated under TNF? and IL1? stimulation. Our data showed that PGRN is able to significantly counteract the IL1?-induced expression of NOS2, COX2, MMP13 and VCAM-1. LPS-induced expression of NOS2 is also decreased by PGRN. These effects are mediated, at least in part, through TNFR1. Taken together, our results suggest that PGRN has a clear antiinflammatory function.
Fuente: Scientific Reports 2016 | 6:20356
Editorial: Nature Publishing Group
Año de publicación: 2016
Nº de páginas: 9
Tipo de publicación: Artículo de Revista
DOI: 10.1038/srep20356
ISSN: 2045-2322
Consultar en UCrea Leer publicación
ABELLA, VANESSA
SCOTECE, MORENA
CONDE, JAVIER
LÓPEZ, VERÓNICA
PIROZZI, CLAUDIO
PINO, JESÚS
GÓMEZ, RODOLFO
LAGO, FRANCISCA
MIGUEL ANGEL GONZALEZ-GAY MANTECON
GUALILLO, ORESTE
Volver